Chemokine Therapeutics Corp.
TSX : CTI
OTC Bulletin Board : CHKT

Chemokine Therapeutics Corp.

May 06, 2008 09:00 ET

Chemokine Therapeutics to Present at BioFinance 2008 Investor Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 6, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX:CTI)(OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that Mr. Walter Korz, President and CEO will be presenting at the BioFinance 2008 Investor Conference in Toronto, Canada on Wednesday May 7th, 2008. Mr. Korz will provide an overview of the Company and an update on the Company's two lead drug candidates, CTCE-9908 for the treatment of cancer and CTCE-0214 for immune system support, both in human clinical trials.

BioFinance 2008 is the Canadian Life Science industry's leading investor conference. The meeting brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology, medical devices, diagnostics and research tools. Participants include senior life science executives, institutional and venture capital investors, industry analysts, corporate finance executives and experts from the scientific and medical communities in Canada, the United States, Europe and Asia.

When: Wednesday May 7th at 10:00 AM EST.

Website: www.biofinance.ca

About Chemokine Therapeutics Corp. (TSX:CTI)(OTCBB:CHKT)

Chemokine Therapeutics is a product-focused biotechnology company developing drug candidates in the field of chemokines. Chemokines are a class of signaling proteins that play a critical role in the growth, differentiation, and maturation of cells necessary for fighting infection as well as tissue repair and regeneration. Chemokines also have an important role in cancer metastasis and growth. Chemokine Therapeutics is a leader in research in the field of chemokines and has several products in various stages of development.

Contact Information

  • Chemokine Therapeutics Corp.
    Mr. Don Evans
    Vice President, Corporate Communications
    (604) 822-0305 or 1-888-822-0305
    (604) 822-0302 (FAX)
    Email: devans@chemokine.net
    Website: www.chemokine.net